Schwab Health Care Fund
Type:
Mutual Funds
Symbol: SWHFX
Net Expense Ratio: 0.800%
Summary
Objective
The fund seeks long-term capital growth.
Highlights
- An actively managed fund that offers convenient access to the health care sector
- Provides exposure to a range of health care companies, such as pharmaceutical and biotechnology companies and medical product manufacturers and suppliers
- Seeks to deliver consistent, risk-adjusted excess return through a disciplined investment process that uses that uses Schwab Equity Ratings® and Schwab's proprietary international stock research as one of several inputs*
- An experienced investment team evaluates securities based on three components: fundamentals, valuation, and momentum
Fund Details
Fund Profile
| Fund Inception | 07/03/2000 | |
|---|---|---|
| Total Net Assets As of 05/29/2020 |
05/29/2020 | $773,774,465.02 |
| Index Name | Dow Jones Global Health Care Index | |
| Shares Outstanding As of 05/29/2020 |
05/29/2020 | 29,352,881 |
| NAV As of 05/29/2020 |
05/29/2020 | $26.36 |
| Total Holdings As of 03/31/2020 |
03/31/2020 | 79 |
| Portfolio Turnover Rate As of 04/30/2020 |
04/30/2020 | 53.50% |
| Morningstar Category | Health | |
| Management Style | Active |
Yields
| SEC Yield (30 Day) As of 05/28/2020 |
05/28/2020 | 0.00% |
|---|---|---|
| Distribution Yield (TTM) As of 04/30/2020 |
04/30/2020 | 1.12% |
Fees & Minimum
| Gross Expense Ratio † | 0.800% | |
|---|---|---|
| Net Expense Ratio † | 0.800% |
Fund Characteristics
| Weighted Average Market Capitalization As of 03/31/2020 |
03/31/2020 | $126.17B |
|---|---|---|
| Price to Earnings Ratio As of 03/31/2020 |
03/31/2020 | 20.43 |
| Price to Book Ratio As of 03/31/2020 |
03/31/2020 | 4.23 |
| Price to Cash Flow As of 03/31/2020 |
03/31/2020 | 13.84 |
| Return on Equity As of 03/31/2020 |
03/31/2020 | 27.54% |
| Alpha (3 Yr) As of 04/30/2020 |
04/30/2020 | -1.63 |
| Beta vs. Benchmark (3 Yr) As of 04/30/2020 |
04/30/2020 | 1.01 |
| R Squared (3 Yr) As of 04/30/2020 |
04/30/2020 | 96.94 |
| Sharpe Ratio (3 Yr) As of 04/30/2020 |
04/30/2020 | 0.53 |
| Standard Deviation (3 Yr) As of 04/30/2020 |
04/30/2020 | 14.57% |
Performance
Total Return
Monthly
04/30/2020
-
SWHFX
Cumulative Returns (%)
- 1 Month
- +11.77
- 3 Month
- +0.68
- YTD
- -1.74
Annualized Returns (%)
- 1 Year
- +11.28
- 3 Year
- +9.53
- 5 Year
- +6.70
- 10 Year
- +13.91
- Inception
- +9.22
-
Dow Jones Global Health Care Index (Index)
Cumulative Returns (%)
- 1 Month
- +11.55
- 3 Month
- +0.32
- YTD
- -1.21
Annualized Returns (%)
- 1 Year
- +14.46
- 3 Year
- +11.23
- 5 Year
- +7.21
- 10 Year
- +12.75
-
Health (Morningstar Category)
Cumulative Returns (%)
- 1 Month
- +14.13
- 3 Month
- +1.08
- YTD
- -1.85
Annualized Returns (%)
- 1 Year
- +13.25
- 3 Year
- +10.50
- 5 Year
- +6.62
- 10 Year
- +14.04
| Description | Cumulative Returns (%) | Annualized Returns (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 Month | 3 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | Inception | ||
| SWHFX | +11.77 | +0.68 | -1.74 | +11.28 | +9.53 | +6.70 | +13.91 | +9.22 | |
| Dow Jones Global Health Care Index (Index) | +11.55 | +0.32 | -1.21 | +14.46 | +11.23 | +7.21 | +12.75 | ||
| Health (Morningstar Category) | +14.13 | +1.08 | -1.85 | +13.25 | +10.50 | +6.62 | +14.04 | ||
Annualized returns for periods 1 yr+/cumulative returns for periods less than 1 yr.
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.
Fund inception date is 07/03/2000.
Quarterly
03/31/2020
-
SWHFX
Average Annual Returns (%)
- 1 Year
- -3.76
- 3 Year
- +6.14
- 5 Year
- +4.11
- 10 Year
- +12.35
- Inception
- +8.65
-
Dow Jones Global Health Care Index (Index)
Average Annual Returns (%)
- 1 Year
- -0.03
- 3 Year
- +7.99
- 5 Year
- +4.91
- 10 Year
- +11.16
-
Health (Morningstar Category)
Average Annual Returns (%)
- 1 Year
- -3.97
- 3 Year
- +6.41
- 5 Year
- +3.27
- 10 Year
- +12.40
| Description | Average Annual Returns (%) | |||||
|---|---|---|---|---|---|---|
| 1 Year | 3 Year | 5 Year | 10 Year | Inception | ||
| SWHFX | -3.76 | +6.14 | +4.11 | +12.35 | +8.65 | |
| Dow Jones Global Health Care Index (Index) | -0.03 | +7.99 | +4.91 | +11.16 | ||
| Health (Morningstar Category) | -3.97 | +6.41 | +3.27 | +12.40 | ||
Annualized returns for periods 1 yr+/cumulative returns for periods less than 1 yr.
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.
Fund inception date is 07/03/2000.
After Tax Returns
As of 03/31/2020
Pre-Liquidation
SWHFX NAV Return
-
SEC Pre-Liquidation
Average Annual Returns (%)
- 1 Year
- -4.76
- 3 Year
- +4.44
- 5 Year
- +2.09
- 10 Year
- +10.34
- Inception
- +7.58
-
SEC Post-Liquidation
Average Annual Returns (%)
- 1 Year
- -1.34
- 3 Year
- +4.76
- 5 Year
- +2.89
- 10 Year
- +9.86
- Inception
- +7.17
-
Tax Cost Ratio
Average Annual Returns (%)
- 1 Year
- +1.23
- 3 Year
- +1.76
- 5 Year
- +2.08
- 10 Year
- +1.95
- Inception
- +1.08
| Description | Average Annual Returns (%) | |||||
|---|---|---|---|---|---|---|
| 1 Year | 3 Year | 5 Year | 10 Year | Inception | ||
| SEC Pre-Liquidation | -4.76 | +4.44 | +2.09 | +10.34 | +7.58 | |
| SEC Post-Liquidation | -1.34 | +4.76 | +2.89 | +9.86 | +7.17 | |
| Tax Cost Ratio | +1.23 | +1.76 | +2.08 | +1.95 | +1.08 | |
After tax returns are based on highest Federal income tax bracket. State taxes are not included. Pre-liquidation figures include taxes on fund's distributions of dividends and capital gains. Tax Cost Ratio represents the percentage-point reduction in returns that results from Federal income taxes (before shares in the fund are sold, and assuming the highest Federal tax bracket).
Health NAV Returns (Morningstar Category)
-
SEC Pre-Liquidation
Average Annual Returns (%)
- 1 Year
- -5.20
- 3 Year
- +5.18
- 5 Year
- +1.88
- 10 Year
- +11.02
-
SEC Post-Liquidation
Average Annual Returns (%)
- 1 Year
- -2.18
- 3 Year
- +4.71
- 5 Year
- +2.24
- 10 Year
- +9.96
-
Tax Cost Ratio
Average Annual Returns (%)
- 1 Year
- --
- 3 Year
- --
- 5 Year
- --
- 10 Year
- --
| Description | Average Annual Returns (%) | |||||
|---|---|---|---|---|---|---|
| 1 Year | 3 Year | 5 Year | 10 Year | Inception | ||
| SEC Pre-Liquidation | -5.20 | +5.18 | +1.88 | +11.02 | ||
| SEC Post-Liquidation | -2.18 | +4.71 | +2.24 | +9.96 | ||
| Tax Cost Ratio | -- | -- | -- | -- | ||
Post-Liquidation
SWHFX NAV Return
-
SEC Pre-Liquidation
Average Annual Returns (%)
- 1 Year
- -4.76
- 3 Year
- +4.44
- 5 Year
- +2.09
- 10 Year
- +10.34
- Inception
- +7.58
-
SEC Post-Liquidation
Average Annual Returns (%)
- 1 Year
- -1.34
- 3 Year
- +4.76
- 5 Year
- +2.89
- 10 Year
- +9.86
- Inception
- +7.17
-
Tax Cost Ratio
Average Annual Returns (%)
- 1 Year
- +1.23
- 3 Year
- +1.76
- 5 Year
- +2.08
- 10 Year
- +1.95
- Inception
- +1.08
| Description | Average Annual Returns (%) | |||||
|---|---|---|---|---|---|---|
| 1 Year | 3 Year | 5 Year | 10 Year | Inception | ||
| SEC Pre-Liquidation | -4.76 | +4.44 | +2.09 | +10.34 | +7.58 | |
| SEC Post-Liquidation | -1.34 | +4.76 | +2.89 | +9.86 | +7.17 | |
| Tax Cost Ratio | +1.23 | +1.76 | +2.08 | +1.95 | +1.08 | |
After tax returns are based on highest Federal income tax bracket. State taxes are not included. Pre-liquidation figures include taxes on fund's distributions of dividends and capital gains. Tax Cost Ratio represents the percentage-point reduction in returns that results from Federal income taxes (before shares in the fund are sold, and assuming the highest Federal tax bracket).
Health NAV Returns (Morningstar Category)
-
SEC Pre-Liquidation
Average Annual Returns (%)
- 1 Year
- -5.20
- 3 Year
- +5.18
- 5 Year
- +1.88
- 10 Year
- +11.02
-
SEC Post-Liquidation
Average Annual Returns (%)
- 1 Year
- -2.18
- 3 Year
- +4.71
- 5 Year
- +2.24
- 10 Year
- +9.96
-
Tax Cost Ratio
Average Annual Returns (%)
- 1 Year
- --
- 3 Year
- --
- 5 Year
- --
- 10 Year
- --
| Description | Average Annual Returns (%) | |||||
|---|---|---|---|---|---|---|
| 1 Year | 3 Year | 5 Year | 10 Year | Inception | ||
| SEC Pre-Liquidation | -5.20 | +5.18 | +1.88 | +11.02 | ||
| SEC Post-Liquidation | -2.18 | +4.71 | +2.24 | +9.96 | ||
| Tax Cost Ratio | -- | -- | -- | -- | ||
Rank within Category
Total Return % as of 04/30/2020
Morningstar Category - Health
-
TOP 25%
- 2020 YTD
Yearly Performance
- 2019
- 2018
- 2017
- 2016
- -4.35
- 2015
- 2014
- 2013
- 2012
- 2011
- +11.53
-
- 2020 YTD
Yearly Performance
- 2019
- 2018
- +3.98
- 2017
- 2016
- 2015
- +8.42
- 2014
- 2013
- 2012
- +19.21
- 2011
-
- 2020 YTD
- -1.74
Yearly Performance
- 2019
- 2018
- 2017
- +20.20
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
-
BOTTOM 25%
- 2020 YTD
Yearly Performance
- 2019
- +17.64
- 2018
- 2017
- 2016
- 2015
- 2014
- +21.50
- 2013
- +39.95
- 2012
- 2011
| Rank | 2020 YTD | Yearly Performance | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
| TOP 25% | -4.35 | +11.53 | |||||||||
| +3.98 | +8.42 | +19.21 | |||||||||
| -1.74 | +20.20 | ||||||||||
| BOTTOM 25% | +17.64 | +21.50 | +39.95 | ||||||||
Rank within Category compares this fund's total annual return to that of other funds in the same category and its figures are not adjusted for any fees and expenses, loads, sales charges, or taxes. See the Monthly Returns table for load-adjusted performance.
© 2020 Morningstar. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Cumulative Growth of a $10,000 Investment
As of 04/30/2020
| SWHFX (Fund) | $39,696 | |
|---|---|---|
| Dow Jones Global Health Care Index (Index) | $35,926 | |
| Health (Morningstar Category) | $42,745 | |
| Worst Three Months Return (12/31/2019 - 3/31/2020) | -12.09 | |
| Best Three Months Return (12/31/2012 - 3/31/2013) | +16.01 |
This graph represents the growth of a hypothetical investment of $10,000. It assumes reinvestment of dividends and capital gains, and does not reflect sales loads, redemption fees or the effects of taxes on any capital gains and/or distributions. If the inception date of the Index is less than the time period shown above, the Since Inception period is shown. Best and Worst Return cover the timeframe of the chart.
Price Performance
Portfolio
Top Holdings
As of 03/31/2020
-
JNJ
- Name
- JOHNSON + JOHNSON COMMON STOCK USD1.0
- Percent of Assets (%)
- 8.24%
- Market Value
- $55.0M
-
MRK
- Name
- MERCK + CO. INC. COMMON STOCK USD.5
- Percent of Assets (%)
- 6.16%
- Market Value
- $41.1M
-
PFE
- Name
- PFIZER INC COMMON STOCK USD.05
- Percent of Assets (%)
- 4.54%
- Market Value
- $30.3M
-
UNH
- Name
- UNITEDHEALTH GROUP INC COMMON STOCK USD.01
- Percent of Assets (%)
- 4.54%
- Market Value
- $30.3M
-
ROG
- Name
- ROCHE HOLDING AG GENUSSCHEIN COMMON STOCK
- Percent of Assets (%)
- 4.44%
- Market Value
- $29.6M
-
AMGN
- Name
- AMGEN INC COMMON STOCK USD.0001
- Percent of Assets (%)
- 4.23%
- Market Value
- $28.2M
-
MDT
- Name
- MEDTRONIC PLC COMMON STOCK USD.1
- Percent of Assets (%)
- 3.98%
- Market Value
- $26.5M
-
ABBV
- Name
- ABBVIE INC COMMON STOCK USD.01
- Percent of Assets (%)
- 3.79%
- Market Value
- $25.3M
-
ABT
- Name
- ABBOTT LABORATORIES COMMON STOCK
- Percent of Assets (%)
- 3.40%
- Market Value
- $22.7M
-
GILD
- Name
- GILEAD SCIENCES INC COMMON STOCK USD.001
- Percent of Assets (%)
- 3.33%
- Market Value
- $22.2M
| Symbol | Name | Percent of Assets (%) | Market Value | ||
|---|---|---|---|---|---|
| JNJ | JOHNSON + JOHNSON COMMON STOCK USD1.0 | 8.24%
|
$55.0M | ||
| MRK | MERCK + CO. INC. COMMON STOCK USD.5 | 6.16%
|
$41.1M | ||
| PFE | PFIZER INC COMMON STOCK USD.05 | 4.54%
|
$30.3M | ||
| UNH | UNITEDHEALTH GROUP INC COMMON STOCK USD.01 | 4.54%
|
$30.3M | ||
| ROG | ROCHE HOLDING AG GENUSSCHEIN COMMON STOCK | 4.44%
|
$29.6M | ||
| AMGN | AMGEN INC COMMON STOCK USD.0001 | 4.23%
|
$28.2M | ||
| MDT | MEDTRONIC PLC COMMON STOCK USD.1 | 3.98%
|
$26.5M | ||
| ABBV | ABBVIE INC COMMON STOCK USD.01 | 3.79%
|
$25.3M | ||
| ABT | ABBOTT LABORATORIES COMMON STOCK | 3.40%
|
$22.7M | ||
| GILD | GILEAD SCIENCES INC COMMON STOCK USD.001 | 3.33%
|
$22.2M |
All Holdings
As of 03/31/2020
Export Data
-
JNJ
- Name
- JOHNSON + JOHNSON COMMON STOCK USD1.0
- % of Assets
- 8.24
- Market Value
- $55.0M
-
MRK
- Name
- MERCK + CO. INC. COMMON STOCK USD.5
- % of Assets
- 6.16
- Market Value
- $41.1M
-
PFE
- Name
- PFIZER INC COMMON STOCK USD.05
- % of Assets
- 4.54
- Market Value
- $30.3M
-
UNH
- Name
- UNITEDHEALTH GROUP INC COMMON STOCK USD.01
- % of Assets
- 4.54
- Market Value
- $30.3M
-
ROG
- Name
- ROCHE HOLDING AG GENUSSCHEIN COMMON STOCK
- % of Assets
- 4.44
- Market Value
- $29.6M
-
AMGN
- Name
- AMGEN INC COMMON STOCK USD.0001
- % of Assets
- 4.23
- Market Value
- $28.2M
-
MDT
- Name
- MEDTRONIC PLC COMMON STOCK USD.1
- % of Assets
- 3.98
- Market Value
- $26.5M
-
ABBV
- Name
- ABBVIE INC COMMON STOCK USD.01
- % of Assets
- 3.79
- Market Value
- $25.3M
-
ABT
- Name
- ABBOTT LABORATORIES COMMON STOCK
- % of Assets
- 3.40
- Market Value
- $22.7M
-
GILD
- Name
- GILEAD SCIENCES INC COMMON STOCK USD.001
- % of Assets
- 3.33
- Market Value
- $22.2M
-
TMO
- Name
- THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0
- % of Assets
- 3.28
- Market Value
- $21.9M
-
NOVN
- Name
- NOVARTIS AG REG COMMON STOCK CHF.5
- % of Assets
- 3.12
- Market Value
- $20.8M
-
NOVOB
- Name
- NOVO NORDISK A/S B COMMON STOCK DKK.2
- % of Assets
- 3.06
- Market Value
- $20.4M
-
BMY
- Name
- BRISTOL MYERS SQUIBB CO COMMON STOCK USD.1
- % of Assets
- 2.81
- Market Value
- $18.7M
-
LLY
- Name
- ELI LILLY + CO COMMON STOCK
- % of Assets
- 2.57
- Market Value
- $17.2M
-
VRTX
- Name
- VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01
- % of Assets
- 1.96
- Market Value
- $13.1M
-
7741
- Name
- HOYA CORP COMMON STOCK
- % of Assets
- 1.80
- Market Value
- $12.0M
-
A
- Name
- AGILENT TECHNOLOGIES INC COMMON STOCK USD.01
- % of Assets
- 1.65
- Market Value
- $11.0M
-
BIIB
- Name
- BIOGEN INC COMMON STOCK USD.0005
- % of Assets
- 1.65
- Market Value
- $11.0M
-
ANTM
- Name
- ANTHEM INC COMMON STOCK USD.01
- % of Assets
- 1.62
- Market Value
- $10.8M
-
ZTS
- Name
- ZOETIS INC COMMON STOCK USD.01
- % of Assets
- 1.62
- Market Value
- $10.8M
-
EW
- Name
- EDWARDS LIFESCIENCES CORP COMMON STOCK USD1.0
- % of Assets
- 1.53
- Market Value
- $10.2M
-
HOLX
- Name
- HOLOGIC INC COMMON STOCK USD.01
- % of Assets
- 1.48
- Market Value
- $9.9M
-
GLPG
- Name
- GALAPAGOS NV COMMON STOCK
- % of Assets
- 1.22
- Market Value
- $8.2M
-
CSL
- Name
- CSL LTD COMMON STOCK
- % of Assets
- 1.17
- Market Value
- $7.8M
-
MOH
- Name
- MOLINA HEALTHCARE INC COMMON STOCK USD.001
- % of Assets
- 1.12
- Market Value
- $7.4M
-
ALXN
- Name
- ALEXION PHARMACEUTICALS INC COMMON STOCK USD.0001
- % of Assets
- 1.10
- Market Value
- $7.4M
-
MCK
- Name
- MCKESSON CORP COMMON STOCK USD.01
- % of Assets
- 1.06
- Market Value
- $7.1M
-
CVS
- Name
- CVS HEALTH CORP COMMON STOCK USD.01
- % of Assets
- 1.04
- Market Value
- $6.9M
-
TECH
- Name
- BIO TECHNE CORP COMMON STOCK USD.01
- % of Assets
- 1.02
- Market Value
- $6.8M
-
HRC
- Name
- HILL ROM HOLDINGS INC COMMON STOCK
- % of Assets
- 1.01
- Market Value
- $6.7M
-
HCA
- Name
- HCA HEALTHCARE INC COMMON STOCK USD.01
- % of Assets
- 0.91
- Market Value
- $6.1M
-
DHR
- Name
- DANAHER CORP COMMON STOCK USD.01
- % of Assets
- 0.88
- Market Value
- $5.8M
-
STE
- Name
- STERIS PLC COMMON STOCK USD75.0
- % of Assets
- 0.83
- Market Value
- $5.5M
-
HZNP
- Name
- HORIZON THERAPEUTICS PLC COMMON STOCK USD.0001
- % of Assets
- 0.82
- Market Value
- $5.4M
-
PHBN
- Name
- SONOVA HOLDING AG REG COMMON STOCK CHF.05
- % of Assets
- 0.80
- Market Value
- $5.3M
-
INCY
- Name
- INCYTE CORP COMMON STOCK USD.001
- % of Assets
- 0.70
- Market Value
- $4.7M
-
AMED
- Name
- AMEDISYS INC COMMON STOCK USD.001
- % of Assets
- 0.69
- Market Value
- $4.6M
-
XRAY
- Name
- DENTSPLY SIRONA INC COMMON STOCK USD.01
- % of Assets
- 0.68
- Market Value
- $4.6M
-
JAZZ
- Name
- JAZZ PHARMACEUTICALS PLC COMMON STOCK USD.0001
- % of Assets
- 0.64
- Market Value
- $4.3M
-
2269
- Name
- WUXI BIOLOGICS CAYMAN INC COMMON STOCK USD.000025
- % of Assets
- 0.62
- Market Value
- $4.1M
-
867
- Name
- CHINA MEDICAL SYSTEM HOLDING COMMON STOCK USD.005
- % of Assets
- 0.62
- Market Value
- $4.1M
-
FPH
- Name
- FISHER + PAYKEL HEALTHCARE C COMMON STOCK
- % of Assets
- 0.52
- Market Value
- $3.5M
-
HUM
- Name
- HUMANA INC COMMON STOCK USD.166
- % of Assets
- 0.51
- Market Value
- $3.4M
-
CI
- Name
- CIGNA CORP COMMON STOCK USD.01
- % of Assets
- 0.50
- Market Value
- $3.3M
-
NUVA
- Name
- NUVASIVE INC COMMON STOCK USD.001
- % of Assets
- 0.47
- Market Value
- $3.1M
-
WST
- Name
- WEST PHARMACEUTICAL SERVICES COMMON STOCK USD.25
- % of Assets
- 0.44
- Market Value
- $2.9M
-
CHE
- Name
- CHEMED CORP COMMON STOCK USD1.0
- % of Assets
- 0.42
- Market Value
- $2.8M
-
ZBH
- Name
- ZIMMER BIOMET HOLDINGS INC COMMON STOCK USD.01
- % of Assets
- 0.42
- Market Value
- $2.8M
-
7733
- Name
- OLYMPUS CORP COMMON STOCK
- % of Assets
- 0.41
- Market Value
- $2.7M
-
EBS
- Name
- EMERGENT BIOSOLUTIONS INC COMMON STOCK USD.001
- % of Assets
- 0.39
- Market Value
- $2.6M
-
EUZ
- Name
- ECKERT + ZIEGLER STRAHLEN UN COMMON STOCK
- % of Assets
- 0.34
- Market Value
- $2.3M
-
A068270
- Name
- CELLTRION INC COMMON STOCK KRW1000.0
- % of Assets
- 0.31
- Market Value
- $2.0M
-
TFX
- Name
- TELEFLEX INC COMMON STOCK USD1.0
- % of Assets
- 0.30
- Market Value
- $2.0M
-
FRE
- Name
- FRESENIUS SE + CO KGAA COMMON STOCK
- % of Assets
- 0.29
- Market Value
- $1.9M
-
A096530
- Name
- SEEGENE INC COMMON STOCK KRW500.
- % of Assets
- 0.27
- Market Value
- $1.8M
-
1558
- Name
- YICHANG HEC CHANGJIANG PHA H COMMON STOCK CNY1.0
- % of Assets
- 0.27
- Market Value
- $1.8M
-
IDXX
- Name
- IDEXX LABORATORIES INC COMMON STOCK USD.1
- % of Assets
- 0.25
- Market Value
- $1.7M
-
1513
- Name
- LIVZON PHARMACEUTICAL GROU H COMMON STOCK CNY1.0
- % of Assets
- 0.25
- Market Value
- $1.7M
-
4568
- Name
- DAIICHI SANKYO CO LTD COMMON STOCK
- % of Assets
- 0.24
- Market Value
- $1.6M
-
CAH
- Name
- CARDINAL HEALTH INC COMMON STOCK
- % of Assets
- 0.22
- Market Value
- $1.5M
-
GSK
- Name
- GLAXOSMITHKLINE PLC COMMON STOCK GBP.25
- % of Assets
- 0.22
- Market Value
- $1.5M
-
CRL
- Name
- CHARLES RIVER LABORATORIES COMMON STOCK USD.01
- % of Assets
- 0.19
- Market Value
- $1.2M
-
CNMD
- Name
- CONMED CORP COMMON STOCK USD.01
- % of Assets
- 0.15
- Market Value
- $977.7K
-
MEDP
- Name
- MEDPACE HOLDINGS INC COMMON STOCK USD.01
- % of Assets
- 0.14
- Market Value
- $930.1K
-
RGEN
- Name
- REPLIGEN CORP COMMON STOCK USD.01
- % of Assets
- 0.12
- Market Value
- $813.4K
-
DIM
- Name
- SARTORIUS STEDIM BIOTECH COMMON STOCK EUR.2
- % of Assets
- 0.11
- Market Value
- $745.7K
-
9792
- Name
- NICHIIGAKKAN CO LTD COMMON STOCK
- % of Assets
- 0.11
- Market Value
- $712.0K
-
SHL
- Name
- SONIC HEALTHCARE LTD COMMON STOCK
- % of Assets
- 0.10
- Market Value
- $681.8K
-
PME
- Name
- PRO MEDICUS LTD COMMON STOCK
- % of Assets
- 0.10
- Market Value
- $663.8K
-
VIRP
- Name
- VIRBAC SA COMMON STOCK EUR1.25
- % of Assets
- 0.06
- Market Value
- $405.3K
-
--
- Name
- TIME DEPOSITS
- % of Assets
- 0.06
- Market Value
- $378.8K
-
4105
- Name
- TTY BIOPHARM CO LTD COMMON STOCK TWD10.
- % of Assets
- 0.05
- Market Value
- $348.9K
-
LNTH
- Name
- LANTHEUS HOLDINGS INC COMMON STOCK USD.01
- % of Assets
- 0.04
- Market Value
- $276.9K
-
--
- Name
- DANISH KRONE
- % of Assets
- 0.03
- Market Value
- $197.2K
-
--
- Name
- AUSTRALIAN DOLLAR
- % of Assets
- 0.00
- Market Value
- $2.6K
-
--
- Name
- SOUTH KOREAN WON
- % of Assets
- 0.00
- Market Value
- $237.7
-
--
- Name
- HONG KONG DOLLAR
- % of Assets
- 0.00
- Market Value
- $62.8
-
--
- Name
- SWISS FRANC
- % of Assets
- 0.00
- Market Value
- $-175.3
| Symbol | Name | % of Assets | Market Value | ||
|---|---|---|---|---|---|
| JNJ | JOHNSON + JOHNSON COMMON STOCK USD1.0 | 8.24 | $55.0M | ||
| MRK | MERCK + CO. INC. COMMON STOCK USD.5 | 6.16 | $41.1M | ||
| PFE | PFIZER INC COMMON STOCK USD.05 | 4.54 | $30.3M | ||
| UNH | UNITEDHEALTH GROUP INC COMMON STOCK USD.01 | 4.54 | $30.3M | ||
| ROG | ROCHE HOLDING AG GENUSSCHEIN COMMON STOCK | 4.44 | $29.6M | ||
| AMGN | AMGEN INC COMMON STOCK USD.0001 | 4.23 | $28.2M | ||
| MDT | MEDTRONIC PLC COMMON STOCK USD.1 | 3.98 | $26.5M | ||
| ABBV | ABBVIE INC COMMON STOCK USD.01 | 3.79 | $25.3M | ||
| ABT | ABBOTT LABORATORIES COMMON STOCK | 3.40 | $22.7M | ||
| GILD | GILEAD SCIENCES INC COMMON STOCK USD.001 | 3.33 | $22.2M | ||
| TMO | THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0 | 3.28 | $21.9M | ||
| NOVN | NOVARTIS AG REG COMMON STOCK CHF.5 | 3.12 | $20.8M | ||
| NOVOB | NOVO NORDISK A/S B COMMON STOCK DKK.2 | 3.06 | $20.4M | ||
| BMY | BRISTOL MYERS SQUIBB CO COMMON STOCK USD.1 | 2.81 | $18.7M | ||
| LLY | ELI LILLY + CO COMMON STOCK | 2.57 | $17.2M | ||
| VRTX | VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01 | 1.96 | $13.1M | ||
| 7741 | HOYA CORP COMMON STOCK | 1.80 | $12.0M | ||
| A | AGILENT TECHNOLOGIES INC COMMON STOCK USD.01 | 1.65 | $11.0M | ||
| BIIB | BIOGEN INC COMMON STOCK USD.0005 | 1.65 | $11.0M | ||
| ANTM | ANTHEM INC COMMON STOCK USD.01 | 1.62 | $10.8M | ||
| ZTS | ZOETIS INC COMMON STOCK USD.01 | 1.62 | $10.8M | ||
| EW | EDWARDS LIFESCIENCES CORP COMMON STOCK USD1.0 | 1.53 | $10.2M | ||
| HOLX | HOLOGIC INC COMMON STOCK USD.01 | 1.48 | $9.9M | ||
| GLPG | GALAPAGOS NV COMMON STOCK | 1.22 | $8.2M | ||
| CSL | CSL LTD COMMON STOCK | 1.17 | $7.8M | ||
| MOH | MOLINA HEALTHCARE INC COMMON STOCK USD.001 | 1.12 | $7.4M | ||
| ALXN | ALEXION PHARMACEUTICALS INC COMMON STOCK USD.0001 | 1.10 | $7.4M | ||
| MCK | MCKESSON CORP COMMON STOCK USD.01 | 1.06 | $7.1M | ||
| CVS | CVS HEALTH CORP COMMON STOCK USD.01 | 1.04 | $6.9M | ||
| TECH | BIO TECHNE CORP COMMON STOCK USD.01 | 1.02 | $6.8M | ||
| HRC | HILL ROM HOLDINGS INC COMMON STOCK | 1.01 | $6.7M | ||
| HCA | HCA HEALTHCARE INC COMMON STOCK USD.01 | 0.91 | $6.1M | ||
| DHR | DANAHER CORP COMMON STOCK USD.01 | 0.88 | $5.8M | ||
| STE | STERIS PLC COMMON STOCK USD75.0 | 0.83 | $5.5M | ||
| HZNP | HORIZON THERAPEUTICS PLC COMMON STOCK USD.0001 | 0.82 | $5.4M | ||
| PHBN | SONOVA HOLDING AG REG COMMON STOCK CHF.05 | 0.80 | $5.3M | ||
| INCY | INCYTE CORP COMMON STOCK USD.001 | 0.70 | $4.7M | ||
| AMED | AMEDISYS INC COMMON STOCK USD.001 | 0.69 | $4.6M | ||
| XRAY | DENTSPLY SIRONA INC COMMON STOCK USD.01 | 0.68 | $4.6M | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC COMMON STOCK USD.0001 | 0.64 | $4.3M | ||
| 2269 | WUXI BIOLOGICS CAYMAN INC COMMON STOCK USD.000025 | 0.62 | $4.1M | ||
| 867 | CHINA MEDICAL SYSTEM HOLDING COMMON STOCK USD.005 | 0.62 | $4.1M | ||
| FPH | FISHER + PAYKEL HEALTHCARE C COMMON STOCK | 0.52 | $3.5M | ||
| HUM | HUMANA INC COMMON STOCK USD.166 | 0.51 | $3.4M | ||
| CI | CIGNA CORP COMMON STOCK USD.01 | 0.50 | $3.3M | ||
| NUVA | NUVASIVE INC COMMON STOCK USD.001 | 0.47 | $3.1M | ||
| WST | WEST PHARMACEUTICAL SERVICES COMMON STOCK USD.25 | 0.44 | $2.9M | ||
| CHE | CHEMED CORP COMMON STOCK USD1.0 | 0.42 | $2.8M | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC COMMON STOCK USD.01 | 0.42 | $2.8M | ||
| 7733 | OLYMPUS CORP COMMON STOCK | 0.41 | $2.7M | ||
| EBS | EMERGENT BIOSOLUTIONS INC COMMON STOCK USD.001 | 0.39 | $2.6M | ||
| EUZ | ECKERT + ZIEGLER STRAHLEN UN COMMON STOCK | 0.34 | $2.3M | ||
| A068270 | CELLTRION INC COMMON STOCK KRW1000.0 | 0.31 | $2.0M | ||
| TFX | TELEFLEX INC COMMON STOCK USD1.0 | 0.30 | $2.0M | ||
| FRE | FRESENIUS SE + CO KGAA COMMON STOCK | 0.29 | $1.9M | ||
| A096530 | SEEGENE INC COMMON STOCK KRW500. | 0.27 | $1.8M | ||
| 1558 | YICHANG HEC CHANGJIANG PHA H COMMON STOCK CNY1.0 | 0.27 | $1.8M | ||
| IDXX | IDEXX LABORATORIES INC COMMON STOCK USD.1 | 0.25 | $1.7M | ||
| 1513 | LIVZON PHARMACEUTICAL GROU H COMMON STOCK CNY1.0 | 0.25 | $1.7M | ||
| 4568 | DAIICHI SANKYO CO LTD COMMON STOCK | 0.24 | $1.6M | ||
| CAH | CARDINAL HEALTH INC COMMON STOCK | 0.22 | $1.5M | ||
| GSK | GLAXOSMITHKLINE PLC COMMON STOCK GBP.25 | 0.22 | $1.5M | ||
| CRL | CHARLES RIVER LABORATORIES COMMON STOCK USD.01 | 0.19 | $1.2M | ||
| CNMD | CONMED CORP COMMON STOCK USD.01 | 0.15 | $977.7K | ||
| MEDP | MEDPACE HOLDINGS INC COMMON STOCK USD.01 | 0.14 | $930.1K | ||
| RGEN | REPLIGEN CORP COMMON STOCK USD.01 | 0.12 | $813.4K | ||
| DIM | SARTORIUS STEDIM BIOTECH COMMON STOCK EUR.2 | 0.11 | $745.7K | ||
| 9792 | NICHIIGAKKAN CO LTD COMMON STOCK | 0.11 | $712.0K | ||
| SHL | SONIC HEALTHCARE LTD COMMON STOCK | 0.10 | $681.8K | ||
| PME | PRO MEDICUS LTD COMMON STOCK | 0.10 | $663.8K | ||
| VIRP | VIRBAC SA COMMON STOCK EUR1.25 | 0.06 | $405.3K | ||
| -- | TIME DEPOSITS | 0.06 | $378.8K | ||
| 4105 | TTY BIOPHARM CO LTD COMMON STOCK TWD10. | 0.05 | $348.9K | ||
| LNTH | LANTHEUS HOLDINGS INC COMMON STOCK USD.01 | 0.04 | $276.9K | ||
| -- | DANISH KRONE | 0.03 | $197.2K | ||
| -- | AUSTRALIAN DOLLAR | 0.00 | $2.6K | ||
| -- | SOUTH KOREAN WON | 0.00 | $237.7 | ||
| -- | HONG KONG DOLLAR | 0.00 | $62.8 | ||
| -- | SWISS FRANC | 0.00 | $-175.3 |
Sectors
03/31/2020
| Sector | Percent of Portfolio (%) | |
|---|---|---|
| Health Care | 100.00%
|
Allocations are subject to change.
Market Cap
03/31/2020
| Market Cap | Percent of Portfolio (%) | |
|---|---|---|
| > $70,000 M | 64.84%
|
|
| $15,000-$70,000 M | 19.27%
|
|
| $3,000-$15,000 M | 12.88%
|
|
| $1,000-$3,000 M | 2.47%
|
|
| <$1,000 M | 0.54%
|
Asset Allocation
03/31/2020
| Asset Class | Percent of Portfolio (%) | |
|---|---|---|
| Stocks | 99.94%
|
|
| Cash Investments | 0.06%
|
The percentage of assets as shown may not equal 100% due to unsettled trades.
Distributions
Distributions
-
Ex-Date: 12/18/2019
- Record Date
- 12/17/2019
- Payable Date
- 12/18/2019
- Income
- 0.2854
- Short Term Capital Gain
- --
- Long Term Capital Gain
- 0.8903
- Return of Capital
- --
- Total Distribution
- 1.175700000
-
Ex-Date: 12/14/2018
- Record Date
- 12/13/2018
- Payable Date
- 12/14/2018
- Income
- 0.2350
- Short Term Capital Gain
- 0.1892
- Long Term Capital Gain
- 1.8745
- Return of Capital
- --
- Total Distribution
- 2.298700000
-
Ex-Date: 12/08/2017
- Record Date
- 12/07/2017
- Payable Date
- 12/08/2017
- Income
- 0.2362
- Short Term Capital Gain
- 0.2131
- Long Term Capital Gain
- 1.3234
- Return of Capital
- --
- Total Distribution
- 1.772700000
-
Ex-Date: 12/12/2016
- Record Date
- 12/09/2016
- Payable Date
- 12/12/2016
- Income
- 0.2046
- Short Term Capital Gain
- --
- Long Term Capital Gain
- 0.3650
- Return of Capital
- --
- Total Distribution
- 0.569600000
-
Ex-Date: 12/10/2015
- Record Date
- 12/09/2015
- Payable Date
- 12/10/2015
- Income
- 0.1619
- Short Term Capital Gain
- 1.3314
- Long Term Capital Gain
- 2.2937
- Return of Capital
- --
- Total Distribution
- 3.787000000
-
Ex-Date: 12/09/2014
- Record Date
- 12/08/2014
- Payable Date
- 12/09/2014
- Income
- 0.2137
- Short Term Capital Gain
- 1.3075
- Long Term Capital Gain
- 1.9112
- Return of Capital
- --
- Total Distribution
- 3.432400000
-
Ex-Date: 12/05/2013
- Record Date
- 12/04/2013
- Payable Date
- 12/05/2013
- Income
- 0.1860
- Short Term Capital Gain
- 0.4429
- Long Term Capital Gain
- 1.8154
- Return of Capital
- --
- Total Distribution
- 2.444300000
-
Ex-Date: 12/06/2012
- Record Date
- 12/05/2012
- Payable Date
- 12/06/2012
- Income
- 0.3336
- Short Term Capital Gain
- --
- Long Term Capital Gain
- 2.1728
- Return of Capital
- --
- Total Distribution
- 2.506400000
-
Ex-Date: 12/22/2011